<Action to be taken to study patients when an adverse event occurs> If an adverse event is observed, principal investigator or sub-investigator provides treatment or follow-up to the study patients until the patient recovers from the adverse event or the follow-up is judged to be unneccesary by medically explainable reason. If follow-up examination, additional examination, or re-examination is necessary, they are conducted after obtaining the study patient's informed consent.